Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-Infiltrating Lymphocytes and Cancer Markers in Osteosarcoma: Influence on Patient Survival
José Casanova, Jani Sofia Almeida, John D. Reith, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6075-6075
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

p53/MicroRNA-34 axis in cancer and beyond
Wei Pan, Binshu Chai, Li Langping, et al.
Heliyon (2023) Vol. 9, Iss. 4, pp. e15155-e15155
Open Access | Times Cited: 25
ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression
Xueying An, Wenshu Wu, Lin Yang, et al.
Translational research (2023) Vol. 259, pp. 62-71
Closed Access | Times Cited: 20
Characterization of the tumour microenvironment phenotypes in malignant tissues and pleural effusion from advanced osteoblastic osteosarcoma patients
Zhichang Zhang, Weiping Ji, Jin Huang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 24
Single-cell RNA-seq reveals intratumoral heterogeneity in osteosarcoma patients: A review
Dylan D. Thomas, Ryan A. Lacinski, Brock A. Lindsey
Journal of bone oncology (2023) Vol. 39, pp. 100475-100475
Open Access | Times Cited: 12
The interaction between osteosarcoma and other cells in the bone microenvironment: From mechanism to clinical applications
Jin Zeng, Yi Peng, Dong Wang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 12
Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities
Xinhui Du, Hua Wei, Boya Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review)
Tong Yu, Weibo Jiang, Yang Wang, et al.
International Journal of Oncology (2024) Vol. 64, Iss. 4
Open Access | Times Cited: 4
New insights into the mechanisms of the immune microenvironment and immunotherapy in osteosarcoma
Cong Luo, Xiaoyun Min, Danying Zhang
Frontiers in Immunology (2025) Vol. 15
Open Access
Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma—A Narrative Review
Yuanrui Luo, M. Sun, Linyun Tan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2717-2717
Open Access | Times Cited: 10
From biology to personalized medicine: Recent knowledge in osteosarcoma
Audrey Mohr, Maria Eugénia Marques Da Costa, Olivia Fromigué, et al.
European Journal of Medical Genetics (2024) Vol. 69, pp. 104941-104941
Open Access | Times Cited: 3
Immunotherapy of osteosarcoma based on immune microenvironment modulation
Heping Lian, Jiakui Zhang, Shijiao Hou, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Identification of potential genes associated with metastasis in osteosarcoma: an integrated bioinformatics analysis
I G. E. Wiratnaya, Miriam Ismail, Fariha Hasan
MUSCULOSKELETAL SURGERY (2025)
Closed Access
A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery
Susana Buendía-López, Alba Rubio‐San‐Simón, Jen-Hao Wu, et al.
Clinical & Translational Oncology (2025)
Closed Access
CD44 expression is correlated with osteosarcoma cell progression and immune infiltration and affects the Wnt/β-catenin signaling pathway
Hairu Ji, Lingwei Kong, Yu Wang, et al.
Journal of bone oncology (2023) Vol. 41, pp. 100487-100487
Open Access | Times Cited: 9
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages
Iseulys Richert, Paul BERCHARD, Lhorra Abbes, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4635-4635
Open Access | Times Cited: 9
Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms
Santhasiri Orrapin, Sutpirat Moonmuang, Sasimol Udomruk, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Strategies to Overcome Resistance to Immune-Based Therapies in Osteosarcoma
Claudia Maria Hattinger, Iris C. Salaroglio, Leonardo Fantoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 799-799
Open Access | Times Cited: 8
Nrf2: a key regulator in chemoradiotherapy resistance of osteosarcoma
Xianglin Peng, Jing Feng, Yang Han, et al.
Genes & Diseases (2024) Vol. 12, Iss. 4, pp. 101335-101335
Open Access | Times Cited: 2
CHEMOTHERAPY, IMMUNOTHERAPY, AND TARGETED THERAPY FOR OSTEOSARCOMA: RECENT ADVANCEMENTS
Esther Ekpe Adewuyi, Harshal Chorya, Muili Abdulbasit, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104575-104575
Closed Access | Times Cited: 2
Characterization of the Tumor Microenvironment in Jaw Osteosarcomas, towards Prognostic Markers and New Therapeutic Targets
Hélios Bertin, Sophie Peries, Jérôme Amiaud, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1004-1004
Open Access | Times Cited: 6
Identification of Cell Subpopulations and Interactive Signaling Pathways From a Single-Cell RNA Sequencing Dataset in Osteosarcoma: A Comprehensive Bioinformatics Analysis
Rong Wu, Xiaojie Dou, Haidong Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells
Н. М. Тодосенко, K. А. Yurova, О. Г. Хазиахматова, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2181-2181
Open Access | Times Cited: 6
Expression of the Circadian Clock Gene ARNTL associated with DNA repair gene and prognosis of patient with osteosarcoma
Daliang Kong, Yang Liu, Minglei Zhang
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis (2022) Vol. 825, pp. 111801-111801
Open Access | Times Cited: 5
The prognostic value of tumor-infiltrating lymphocytes in non-small cell lung cancer patients who received neoadjuvant chemotherapy followed by surgery
Zexin Hou, Lili Zhao, Lingjun Zou, et al.
Advances in Clinical and Experimental Medicine (2023) Vol. 32, Iss. 8, pp. 847-853
Open Access | Times Cited: 2
Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma
Dandan Zhang, Zhenhong Jiang, Jianping Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top